National heart, lung, and blood institute type II coronary intervention study: Design, methods, and baseline characteristics
- 30 June 1982
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 3 (2) , 91-111
- https://doi.org/10.1016/0197-2456(82)90038-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The coronary primary prevention trial: Design and implementationJournal of Chronic Diseases, 1979
- George Lyman Duff Memorial Lecture. Lifestyles, major risk factors, proof and public policy.Circulation, 1978
- The Multiple Risk Factor Intervention Trial (MRFIT)Published by American Medical Association (AMA) ,1976
- Treatment of HyperlipidemiaNew England Journal of Medicine, 1974
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974
- Cholestyramine in Type II HyperlipoproteinemiaAnnals of Internal Medicine, 1973
- Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTIONJournal of Clinical Investigation, 1973
- Lipid Lowering Drugs and HyperlipidaemiaDrugs, 1973
- The metabolism of low density lipoprotein in familial type II hyperlipoproteinemiaJournal of Clinical Investigation, 1972
- Selective Coronary ArteriographyRadiology, 1967